カテゴリー： Grand View Research, 世界, 医療/バイオ

院内感染診断の世界市場2024年-2030年：市場規模、シェア、動向分析

◆英語タイトル：Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Conventional), By Infection Type (UTI, Pneumonia), By Product (Consumables), By Type, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV24JAN045）◆商品コード：GRV24JAN045
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年11月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

院内感染診断市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の院内感染診断市場は2030年までに71億5000万ドルに達する見込みです。世界の院内感染診断市場は、2023年から2030年までの期間に7.2%の健全なCAGRで成長すると予測されています。市場成長の要因としては、MRSAやC. difficileのような薬剤耐性病原体の増加、老年人口の高齢化、正確で信頼性の高い結果を短納期で提供する技術的に高度な製品の開発などが挙げられます。

業界成長のもう一つの要因は、中低所得国からのHAI診断薬需要の増加であり、HAI診断薬市場の需要をさらに押し上げています。医療従事者の意識の高まりや政府のイニシアティブの提案が、業界の成長をさらに後押ししています。しかし、先進国における院内感染の有病率の低下は、業界の成長を妨げる可能性が高いです。

HAI診断市場は、感染タイプおよび検査タイプに基づいて分類されます。感染タイプ別では、尿路感染（UTI）、血流感染（BSI）、手術部位感染（SSI）、肺炎、その他に区分されます。2015年現在、尿路感染症分野が最大のシェアを占めると推定される一方、肺炎HAI診断薬は2015年から2022年までの期間、最も高いCAGRで成長すると予測されています。HAI診断薬産業はさらに分子検査とその他の体外検査に細分化されます。分子診断セグメントはシェアが低いが、今後数年で有利な成長が見込まれます。

院内感染診断市場レポートハイライト

- 消耗品セグメントは、2022年の病院内感染診断市場において63.5%の最大売上シェアを占め、HAIの発生率の上昇により、予測期間中最も速いCAGR 7.7%で拡大すると予測されます。

- 血液検査セグメントは、2022年に65.8％の最大の収益シェアを占め、予測期間中に7.08％の最速CAGRで進展すると予測されています。

- 欧州が市場を支配し、2022年には34.3%の最大収益シェアを占めました。これは、高い疾病負担、インフラの利用可能性、医療費の増加、急速な技術進歩、政府の積極的な取り組み、患者意識の高まり、大手企業の存在によるものです。

第1章. 調査手法・範囲
1.1. 市場セグメンテーションと範囲
1.1.1. 検査タイプ
1.1.2. 感染タイプ
1.1.3. 製品
1.1.4. 種類
1.1.5. 地域範囲
1.1.6. 動向・予測スケジュール
1.2. 調査方法
1.3. 情報調達
1.3.1. 購入データベース
1.3.2. GVR社内データベース
1.3.3. 二次情報源
1.3.4. 一次調査
1.3.5. 一次調査の詳細
1.4. 情報またはデータ分析
1.4.1. データ分析モデル
1.5. 市場形成と検証
1.6. モデルの詳細
1.7. 二次情報源のリスト
1.8. 一次資料リスト
1.9. 目的
1.9.1. 目標1
1.9.2. 目標2
第2章 エグゼクティブサマリー
2.1. 市場の展望
2.2. セグメントの展望
2.2.1. 検査タイプの展望
2.2.2. 感染タイプの展望
2.2.3. 製品の展望
2.2.4. タイプの展望
2.2.5. 地域展望
2.3. 競合他社の洞察
第3章. 院内感染診断市場の変数、動向、範囲
3.1. 市場系統の展望
3.1.1. 親市場の展望
3.1.2. 関連・付随市場の展望
3.2. 普及・成長見通しマッピング
3.3. 市場ダイナミクス
3.3.1. 市場ドライバー分析
3.3.2. 市場阻害要因分析
3.4. 院内感染診断市場分析ツール
3.4.1. 産業分析-ポーターの5つの力
3.4.1.1. サプライヤーパワー
3.4.1.2. 買い手の力
3.4.1.3. 代替の脅威
3.4.1.4. 新規参入の脅威
3.4.1.5. 競争上のライバル
3.4.2. PESTEL分析
3.4.2.1. 政治情勢
3.4.2.2. 技術的ランドスケープ
3.4.2.3. 経済情勢
第4章. 院内感染診断市場：検査タイプの予測・動向分析
4.1. 院内感染診断市場 主な要点
4.2. 院内感染診断市場： 検査タイプの動きと市場シェア分析、2022年・2030年
4.3. 従来型
4.3.1. 従来型市場の動向・予測、2018〜2030年（百万米ドル）
4.4. 分子
4.4.1. 分子市場の動向・予測、2018～2030年（百万米ドル）
第5章. 院内感染診断市場：感染タイプの予測・動向分析
5.1. 院内感染診断市場： 主な要点
5.2. 院内感染診断市場： 感染タイプの動きと市場シェア分析、2022年および2030年
5.3. 尿路結石
5.3.1. UTI市場の予測・動向、2018年〜2030年 （百万米ドル）
5.4. 肺炎
5.4.1. 肺炎市場の動向・予測、2018～2030年（百万米ドル）
5.5. 手術部位感染
5.5.1. 手術部位感染市場の動向・予測、2018～2030年（百万米ドル）
5.6. 血流感染
5.6.1. 血流感染市場の動向・予測、2018～2030年（百万米ドル）
5.7. その他
5.7.1. その他の感染症市場の動向・予測、2018～2030年（百万米ドル）
第6章. 院内感染診断市場：製品の予測・動向分析
6.1. 院内感染診断市場 主要なポイント
6.2. 院内感染診断市場： 製品動向と市場シェア分析、2022年・2030年
6.3. 消耗品
6.3.1. 消耗品市場の動向・予測、2018〜2030年 （百万米ドル）
6.4. 器具
6.4.1. インストルメンツ市場の動向・予測、2018～2030年（百万米ドル）
第7章. 院内感染診断市場：タイプ別予測・動向分析
7.1. 院内感染診断市場 主要項目
7.2. 院内感染診断市場： タイプ別動向と市場シェア分析、2022年・2030年
7.3. 血液検査
7.3.1. 血液検査市場の動向・予測、2018〜2030年（百万米ドル）
7.4. 尿検査
7.4.1. 尿検査市場の動向・予測、2018～2030年（百万米ドル）
第8章. 院内感染診断市場：地域別予測・動向分析
8.1. 地域別展望
8.2. 地域別の院内感染診断市場 主要なポイント
8.3. 北米
8.3.1. 市場の予測・動向、2018年～2030年 （売上高、百万米ドル）
8.3.2. 米国
8.3.2.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.3.3. カナダ
8.3.3.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4. 欧州
8.4.1. 英国
8.4.1.1. 市場の動向・予測、2018～2030年 （売上高、百万米ドル）
8.4.2. ドイツ
8.4.2.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4.3. フランス
8.4.3.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4.4. イタリア
8.4.4.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4.5. スペイン
8.4.5.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4.6. デンマーク
8.4.6.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4.7. スウェーデン
8.4.7.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.4.8. ノルウェー
8.4.8.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.5. アジア太平洋
8.5.1. 日本
8.5.1.1. 市場の動向・予測、2018～2030年 （売上高、百万米ドル）
8.5.2. 中国
8.5.2.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.5.3. インド
8.5.3.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.5.4. オーストラリア
8.5.4.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.5.5. タイ
8.5.5.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.5.6. 韓国
8.5.6.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.6. ラテンアメリカ
8.6.1. ブラジル
8.6.1.1. 市場の動向・予測、2018～2030年 （売上高、百万米ドル）
8.6.2. メキシコ
8.6.2.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.6.3. アルゼンチン
8.6.3.1. 市場の動向・予測、2018～2030年（売上高、百万米ドル）
8.7. MEA
8.7.1. 南アフリカ
8.7.1.1. 市場の動向・予測、2018～2030年 （売上高、百万米ドル）
8.7.2. サウジアラビア
8.7.2.1. 市場の推計と予測、2018～2030年（売上高、百万米ドル）
8.7.3. アラブ首長国連邦
8.7.3.1. 市場の予測・動向、2018～2030年（売上高、百万米ドル）
8.7.4. クウェート
8.7.4.1. 市場の予測・動向、2018年～2030年（売上高、百万米ドル）
第9章 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. Infection Type
1.1.3. Product
1.1.4. Type
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.2.2. Infection Type outlook
2.2.3. Product outlook
2.2.4. Type outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Hospitals Acquired Infections Diagnostics Market: Test Type Estimates & Trend Analysis
4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
4.2. Hospital Acquired Infections Diagnostics Market: Test Type Movement & Market Share Analysis, 2022 & 2030
4.3. Conventional
4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Molecular
4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Hospital Acquired Infections Diagnostics Market: Infection Type Estimates & Trend Analysis
5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
5.2. Hospital Acquired Infections Diagnostics Market: Infection Type Movement & Market Share Analysis, 2022 & 2030
5.3. UTI
5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Pneumonia
5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Surgical Site Infection
5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Blood Stream Infections
5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Hospital Acquired Infections Diagnostics Market: Product Estimates & Trend Analysis
6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
6.2. Hospital Acquired Infections Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
6.3. Consumables
6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Instruments
6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis
7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
7.2. Hospital Acquired Infections Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
7.3. Blood Tests
7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Urinalysis
7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Denmark
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Sweden
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Norway
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. BIOMÉRIEUX
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. F. Hoffmann-La Roche Ltd.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Siemens Healthcare Private Limited
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. BD (Becton, Dickinson and Company)
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Hologic, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Meridian Bioscience, Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. QIAGEN
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Thermo Fisher Scientific Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Bioscience, Inc.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018 - 2030 (USD Million)
Table 4 North America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 5 North America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 North America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 U.S. hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 12 Canada hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 13 Canada hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 14 Canada hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 Europe hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 16 Europe hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 17 Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 18 Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 19 Europe hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 20 UK hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 21 UK hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 22 UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 23 UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 24 Germany hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 25 Germany hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 26 Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 27 Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 28 France hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 29 France hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 30 France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 31 France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 32 Italy hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 33 Italy hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 34 Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 35 Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 Spain hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 37 Spain hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 38 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 39 Spain hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 40 Denmark hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 41 Denmark hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 42 Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 43 Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 44 Sweden hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 45 Sweden hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 46 Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 47 Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 48 Norway hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 49 Norway hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 50 Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 51 Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 52 Asia Pacific hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 53 Asia Pacific hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 54 Asia Pacific hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 55 Asia Pacific hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 56 Asia Pacific hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 57 Japan hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Japan hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 59 Japan hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 60 Japan hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 61 China hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 62 China hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 63 China hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 64 China hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 65 India hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 66 India hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 67 India hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 68 India hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 69 Australia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 70 Australia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 71 Australia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 72 Australia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 73 Thailand hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 74 Thailand hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 75 Thailand hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 76 Thailand hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 77 South Korea hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 78 South Korea hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 79 South Korea hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 80 South Korea hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 81 Latin America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 82 Latin America hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 83 Latin America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 84 Latin America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 85 Latin America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 87 Brazil hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 88 Brazil hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 89 Brazil hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 90 Mexico hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 91 Mexico hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 92 Mexico hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 93 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 94 Argentina hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 95 Argentina hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 96 Argentina hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 97 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 104 South Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 105 South Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 106 South Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 111 UAE hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 112 UAE hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 113 UAE hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 114 UAE hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 115 Kuwait hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 116 Kuwait hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 117 Kuwait hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 118 Kuwait hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 院内感染診断の世界市場2024年-2030年：市場規模、シェア、動向分析(Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Conventional), By Infection Type (UTI, Pneumonia), By Product (Consumables), By Type, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • インフルエンザ診断の世界市場2024年-2030年：市場規模、シェア、動向分析
  • 体外診断(IVD)用酵素の世界市場2023年-2030年：市場規模、シェア、動向分析
  • 肝疾患診断の世界市場2024年-2030年：市場規模、シェア、動向分析
  • 敗血症診断の世界市場2024年-2030年：市場規模、シェア、動向分析
  • 腫瘍分子診断の世界市場2024年-2030年：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆